IBDEI1XC ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32638,1,3,0)
 ;;=3^Non-pressure chron ulcer lft ft w/ unsp sev, oth prt
 ;;^UTILITY(U,$J,358.3,32638,1,4,0)
 ;;=4^L97.529
 ;;^UTILITY(U,$J,358.3,32638,2)
 ;;=^5009554
 ;;^UTILITY(U,$J,358.3,32639,0)
 ;;=L97.524^^126^1621^13
 ;;^UTILITY(U,$J,358.3,32639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32639,1,3,0)
 ;;=3^Non-pressure chron ulcer lft ft w/ necr of bone, oth prt
 ;;^UTILITY(U,$J,358.3,32639,1,4,0)
 ;;=4^L97.524
 ;;^UTILITY(U,$J,358.3,32639,2)
 ;;=^5009553
 ;;^UTILITY(U,$J,358.3,32640,0)
 ;;=L97.523^^126^1621^14
 ;;^UTILITY(U,$J,358.3,32640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32640,1,3,0)
 ;;=3^Non-pressure chron ulcer lft ft w/ necr muscle, oth prt
 ;;^UTILITY(U,$J,358.3,32640,1,4,0)
 ;;=4^L97.523
 ;;^UTILITY(U,$J,358.3,32640,2)
 ;;=^5009552
 ;;^UTILITY(U,$J,358.3,32641,0)
 ;;=L97.522^^126^1621^12
 ;;^UTILITY(U,$J,358.3,32641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32641,1,3,0)
 ;;=3^Non-pressure chron ulcer lft ft w/ fat layer exp, oth prt
 ;;^UTILITY(U,$J,358.3,32641,1,4,0)
 ;;=4^L97.522
 ;;^UTILITY(U,$J,358.3,32641,2)
 ;;=^5009551
 ;;^UTILITY(U,$J,358.3,32642,0)
 ;;=L98.499^^126^1621^42
 ;;^UTILITY(U,$J,358.3,32642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32642,1,3,0)
 ;;=3^Non-pressure chron ulcer skin, sites w/ unsp severity
 ;;^UTILITY(U,$J,358.3,32642,1,4,0)
 ;;=4^L98.499
 ;;^UTILITY(U,$J,358.3,32642,2)
 ;;=^5009591
 ;;^UTILITY(U,$J,358.3,32643,0)
 ;;=R26.81^^126^1621^43
 ;;^UTILITY(U,$J,358.3,32643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32643,1,3,0)
 ;;=3^Unsteadiness on Feet
 ;;^UTILITY(U,$J,358.3,32643,1,4,0)
 ;;=4^R26.81
 ;;^UTILITY(U,$J,358.3,32643,2)
 ;;=^5019307
 ;;^UTILITY(U,$J,358.3,32644,0)
 ;;=E53.8^^126^1622^24
 ;;^UTILITY(U,$J,358.3,32644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32644,1,3,0)
 ;;=3^Vitamin B Group Deficiency NEC
 ;;^UTILITY(U,$J,358.3,32644,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,32644,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,32645,0)
 ;;=M21.171^^126^1622^19
 ;;^UTILITY(U,$J,358.3,32645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32645,1,3,0)
 ;;=3^Varus deformity, rt ankl, NEC
 ;;^UTILITY(U,$J,358.3,32645,1,4,0)
 ;;=4^M21.171
 ;;^UTILITY(U,$J,358.3,32645,2)
 ;;=^5011082
 ;;^UTILITY(U,$J,358.3,32646,0)
 ;;=M21.172^^126^1622^18
 ;;^UTILITY(U,$J,358.3,32646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32646,1,3,0)
 ;;=3^Varus deformity, lft ankl, NEC
 ;;^UTILITY(U,$J,358.3,32646,1,4,0)
 ;;=4^M21.172
 ;;^UTILITY(U,$J,358.3,32646,2)
 ;;=^5011083
 ;;^UTILITY(U,$J,358.3,32647,0)
 ;;=Q66.3^^126^1622^17
 ;;^UTILITY(U,$J,358.3,32647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32647,1,3,0)
 ;;=3^Varus Deformity of Foot,Congenital
 ;;^UTILITY(U,$J,358.3,32647,1,4,0)
 ;;=4^Q66.3
 ;;^UTILITY(U,$J,358.3,32647,2)
 ;;=^5018864
 ;;^UTILITY(U,$J,358.3,32648,0)
 ;;=I83.12^^126^1622^1
 ;;^UTILITY(U,$J,358.3,32648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32648,1,3,0)
 ;;=3^Varicose veins lft lwr extrem w/ inflammation
 ;;^UTILITY(U,$J,358.3,32648,1,4,0)
 ;;=4^I83.12
 ;;^UTILITY(U,$J,358.3,32648,2)
 ;;=^5007989
 ;;^UTILITY(U,$J,358.3,32649,0)
 ;;=I83.11^^126^1622^9
 ;;^UTILITY(U,$J,358.3,32649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32649,1,3,0)
 ;;=3^Varicose veins rt lwr extrem w/ inflammation
 ;;^UTILITY(U,$J,358.3,32649,1,4,0)
 ;;=4^I83.11
 ;;^UTILITY(U,$J,358.3,32649,2)
 ;;=^5007988
 ;;^UTILITY(U,$J,358.3,32650,0)
 ;;=I83.212^^126^1622^12
 ;;^UTILITY(U,$J,358.3,32650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32650,1,3,0)
 ;;=3^Varicose veins rt lwr extrem w/ ulc calf & inflammation
